France Intergroupe Syndromes Myéloprolifératifs

">
Previous entity Next entity
logo FIM

FIM

The FIM is a cooperative group of clinicians, biologists and researchers from all over France involved in the diagnosis, management, treatment and research on Ph-negative myeloproliferative disorders.

Image FIM
Jean-Jacques Kiladjian
Prof. Jean-Jacques Kiladjian

Head of Entity

Contact

Email : jean-jacques.kiladjian@aphp.fr

Hôpital Saint Louis AP-HP
1, avenue Claude Vellefaux
75010 Paris - France

Website

Research infrastructures

Preclinical studies In vivo and in vitro drug testing platform in collaboration with UMR 1131 (Dr Bruno Cassinat) and UMR 944 (Dr Lina Benajiba).
Clinical investigation center (CIC) Accredited by INCa as CLIP² Paris Nord since 2010, to facilitate the implementation of early-phase trials in oncology. With continuous improvement at the heart of its activities, the CIC is committed to an Organizational and Participatory Quality approach.
Biological sample  

Various sources

MPN

BCB FIMBANK - National multicenter clinical-biological database of myeloproliferative syndromes.

Various sources

Clinical data

BCB FIMBANK - National multicenter clinical biology database for myeloproliferative disorders.

Partners

Academics

Affiliation

France Intergroupe des syndromes Myéloprolifératifs (FIM)